Companies
/Healthcare
Glaukos Corporation
$154.88
▲ $1.39 (+0.91%) today
Markets closed · 2:05am ET
24/7 Wall St. View
Fundamentals
Market Cap
$9.1B
Profit Margin
-30.7%
Revenue (TTM)
$612.8M
EPS (TTM)
$-3.15
52-Week Range
$73 – $192
Street Target
$198.69
About Glaukos
Glaukos Corporation is a pioneer in eye care, focusing on innovative treatments for glaucoma, corneal disorders, and retinal diseases. Known for its iStent products, which are tiny stents used in cataract surgery to help manage glaucoma, the company is also developing new solutions like the iStent Infinite for severe glaucoma cases and iDose TR for reducing eye pressure. With a commitment to improving patients' vision and quality of life, Glaukos markets its products globally, combining medical technology with pharmaceutical therapies since its founding in 1998 in Aliso Viejo, California.